美国不同年龄、种族/族裔和性别人群处方药滥用的最新趋势。
Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex.
机构信息
Department of Psychology, Texas State University, San Marcos, Texas, USA.
School of Nursing, Center for the Study of Drugs, Alcohol, Smoking and Health, University of Michigan, Ann Arbor, Michigan, USA.
出版信息
Am J Addict. 2022 Sep;31(5):396-402. doi: 10.1111/ajad.13289. Epub 2022 Apr 19.
Abstract
BACKGROUND AND OBJECTIVES
To examine changes in United States past-year opioid, stimulant, and benzodiazepine prescription drug misuse (PDM) and poly-PDM by demographics.
METHODS
Data were from the 2015-2019 National Survey on Drug Use and Health (N = 282,768), examining annualized PDM change by demographics.
RESULTS
Opioid and poly-PDM significantly declined among those under 35 years, White, and multiracial residents.
DISCUSSION AND CONCLUSIONS
Age and race/ethnicity are important moderators of recent PDM trends, warranting investigation of mechanisms.
SCIENTIFIC SIGNIFICANCE
Results highlight ongoing PDM declines in younger groups but expand the literature by showing limited changes in adults 35 and older and non-opioid PDM.
摘要
背景和目的
研究美国过去一年阿片类药物、兴奋剂和苯二氮䓬类处方药物滥用（PDM）和多药滥用（poly-PDM）随人口统计学特征的变化。
方法
数据来自 2015-2019 年全国药物使用与健康调查（N=282768），通过人口统计学特征研究了年度 PDM 变化情况。
结果
在 35 岁以下、白人以及多种族居民中，阿片类药物和多药滥用显著下降。
讨论与结论
年龄和种族/民族是近期 PDM 趋势的重要调节因素，需要对这些机制进行调查。
科学意义
结果突出了年轻群体中持续下降的 PDM，但通过显示 35 岁及以上成年人和非阿片类药物 PDM 变化有限，扩展了相关文献。
相似文献
1
Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex.
Am J Addict. 2022 Sep;31(5):396-402. doi: 10.1111/ajad.13289. Epub 2022 Apr 19.
2
Prescription drug use, misuse and related substance use disorder symptoms vary by educational status and attainment in U.S. adolescents and young adults.
Drug Alcohol Depend. 2018 Aug 1;189:172-177. doi: 10.1016/j.drugalcdep.2018.05.017. Epub 2018 Jun 21.
3
Opioid-involved prescription drug misuse and poly-prescription drug misuse in U.S. older adults.
Aging Ment Health. 2021 Dec;25(12):2365-2373. doi: 10.1080/13607863.2020.1839859. Epub 2020 Nov 2.
4
Prescription Drug Misuse Among U.S. Mothers of Minor Children in 2015-2019: Trends, Profiles, and Behavioral Health Comorbidities.
J Stud Alcohol Drugs. 2022 Sep;83(5):712-720. doi: 10.15288/jsad.21-00343.
5
Poly-prescription drug misuse across the life course: Prevalence and correlates across different adult age cohorts in the U.S.
Int J Drug Policy. 2021 Feb;88:103017. doi: 10.1016/j.drugpo.2020.103017. Epub 2020 Nov 20.
6
Prescription drug misuse, other substance use, and sexual identity: The significance of educational status and psychological distress in US young adults.
Subst Abus. 2021;42(3):377-387. doi: 10.1080/08897077.2020.1784358. Epub 2020 Jul 21.
7
Sources of Prescription Medication Misuse Among Young Adults in the United States: The Role of Educational Status.
J Clin Psychiatry. 2018 Mar/Apr;79(2). doi: 10.4088/JCP.17m11958.
8
Age-specific risk of substance use disorders associated with controlled medication use and misuse subtypes in the United States.
Addict Behav. 2019 Mar;90:285-293. doi: 10.1016/j.addbeh.2018.11.010. Epub 2018 Nov 14.
9
Prescription drug and alcohol simultaneous co-ingestion in U.S. young adults: Prevalence and correlates.
Exp Clin Psychopharmacol. 2022 Dec;30(6):797-808. doi: 10.1037/pha0000519. Epub 2021 Aug 19.
10
Prescription Opioid Misuse and Use of Alcohol and Other Substances Among High School Students - Youth Risk Behavior Survey, United States, 2019.
MMWR Suppl. 2020 Aug 21;69(1):38-46. doi: 10.15585/mmwr.su6901a5.
引用本文的文献
1
Stalled Improvements? Youth Opioid Misuse 2015-2022.
J Adolesc Health. 2025 Aug;77(2):335-337. doi: 10.1016/j.jadohealth.2025.05.008. Epub 2025 Jul 3.
2
Social Withdrawal and Prescription Opioid Misuse Among Older Adults in the United States.
Innov Aging. 2025 May 24;9(6):igaf052. doi: 10.1093/geroni/igaf052. eCollection 2025.
3
Severity of stimulant use disorder by psychostimulant type and polystimulant use pattern.
Exp Clin Psychopharmacol. 2025 Jun;33(3):275-284. doi: 10.1037/pha0000761. Epub 2025 Feb 27.
4
Heterogeneity in Prescription Opioid Misuse Motives by Age in Adolescents and Young Adults in the United States.
J Addict Med. 2024 Dec 9. doi: 10.1097/ADM.0000000000001428.
5
Evolution of the substance use landscape: Implications for contingency management.
J Appl Behav Anal. 2025 Jan;58(1):36-55. doi: 10.1002/jaba.2911. Epub 2024 Aug 28.
6
Age-related Psychometric Dimensionality Using the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition Opioid Use Disorder Diagnostic Criteria.
J Addict Med. 2024;18(6):675-682. doi: 10.1097/ADM.0000000000001343. Epub 2024 Jul 23.
7
Prescription Painkiller Misuse in Hispanic and non-Hispanic Adults Ages 50 and Older: Trends and Correlates in a National Sample, 2015-2019.
Subst Use Misuse. 2024;59(12):1833-1837. doi: 10.1080/10826084.2024.2370024. Epub 2024 Jun 22.
8
Indirect effects of emotion regulation in the relationship between pain and cannabis use in adults 18-64 years.
Addict Behav. 2024 Jun;153:107983. doi: 10.1016/j.addbeh.2024.107983. Epub 2024 Feb 10.
9
Is Early Onset of Nonmedical Prescription Stimulant Use Associated With Cocaine Use During Adolescence? Results From a National Study.
Subst Use Addctn J. 2024 Apr;45(2):314-324. doi: 10.1177/29767342231219139. Epub 2024 Jan 4.
10
College Students' prescription drug misuse over time and links with their mental health and well-being.
Addict Behav. 2024 Feb;149:107895. doi: 10.1016/j.addbeh.2023.107895. Epub 2023 Oct 26.
本文引用的文献
1
Trajectories of Prescription Drug Misuse Among US Adults From Ages 18 to 50 Years.
JAMA Netw Open. 2022 Jan 4;5(1):e2141995. doi: 10.1001/jamanetworkopen.2021.41995.
2
Prescription Opioid Laws and Opioid Dispensing in US Counties: Identifying Salient Law Provisions With Machine Learning.
Epidemiology. 2021 Nov 1;32(6):868-876. doi: 10.1097/EDE.0000000000001404.
3
Heroin use cannot be measured adequately with a general population survey.
Addiction. 2021 Oct;116(10):2600-2609. doi: 10.1111/add.15458. Epub 2021 Mar 27.
4
Promoting Patient-Centeredness in Opioid Deprescribing: a Blueprint for De-implementation Science.
J Gen Intern Med. 2020 Dec;35(Suppl 3):972-977. doi: 10.1007/s11606-020-06254-7. Epub 2020 Nov 3.
5
Trends in stimulant dispensing by age, sex, state of residence, and prescriber specialty - United States, 2014-2019.
Drug Alcohol Depend. 2020 Dec 1;217:108297. doi: 10.1016/j.drugalcdep.2020.108297. Epub 2020 Sep 15.
6
Prescription Drug Misuse: Taking a Lifespan Perspective.
Subst Abuse. 2020 Mar 5;14:1178221820909352. doi: 10.1177/1178221820909352. eCollection 2020.
7
Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297. doi: 10.15585/mmwr.mm6911a4.
8
The epidemiology of benzodiazepine misuse: A systematic review.
Drug Alcohol Depend. 2019 Jul 1;200:95-114. doi: 10.1016/j.drugalcdep.2019.02.033. Epub 2019 May 7.
9
Patterns in Outpatient Benzodiazepine Prescribing in the United States.
JAMA Netw Open. 2019 Jan 4;2(1):e187399. doi: 10.1001/jamanetworkopen.2018.7399.
10
Nonmedical prescription opioids and pathways of drug involvement in the US: Generational differences.
Drug Alcohol Depend. 2018 Jan 1;182:103-111. doi: 10.1016/j.drugalcdep.2017.10.013. Epub 2017 Nov 27.
Zotero 插件